Log In
Print this Print this

NT-503 ECT

Also known as: NT-503

  Manage Alerts
Collapse Summary General Information
Company Neurotech Pharmaceuticals Inc.
DescriptionEncapsulated human cells genetically modified to deliver soluble VEGF receptor
Molecular Target Vascular endothelial growth factor (VEGF)
Mechanism of Action 
Therapeutic ModalityCell therapy

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today